What if Hemophilic Joint Damage Isn’t as Irreversible as We Thought? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Parthiv Sheth et al, adding:
“What if hemophilic joint damage isn’t as irreversible as we thought?
For decades, hemophilic arthropathy has been viewed as a one-way path: bleed to damage, damage to progression.
This new longitudinal ultrasound study challenges that narrative.
Using the JADE musculoskeletal ultrasound protocol, researchers followed adults with hemophilia for up to 3 years and tracked cartilage, bone, and soft-tissue changes across elbows, knees, and ankles.
Here’s the surprising part։
- Joint tissues showed dynamic plasticity over time
- Some unhealthy joints actually showed signs of repair
- Hemarthrosis was linked to cartilage thinning and increased PRO-C4 biomarker turnover
- PRO-C4 may signal ongoing synovial vascular remodeling and subclinical bleeding
- Clinical scores barely changed — while ultrasound detected subclinical tissue trajectories
Translation:
- We may finally have tools to see joint biology evolving in real time — not just the end-stage damage.
This work reframes hemophilic arthropathy as a dynamic, remodeling disease, opening the door to earlier intervention, better monitoring, and new outcome measures for trials.”
Tilte: Joint tissue plasticity in hemophilia: insights from the Joint Activity and Damage Exam ultrasound protocol
Authors: Parthiv Sheth, Khang Tong, Bilgimol Chumappumkal Joseph, Tina Manon-Jensen, Michael Glenzer, Isaac Nwi-Mozu, Peter Aguero, Bruno Steiner, Cindy Bailey, Doris V. Quon, Rebecca Kruse-Jarres, Euyhyun Lee, Morten Asser Karsdal, Lin Liu, Annette von Drygalski
Read the Full Article on RPTH Journal.

Find more posts featuring RPTH Journal on Hemostasis Today.
-
Feb 13, 2026, 13:52Wolfgang Miesbach: Adding Years of Life – and Life to Years
-
Feb 13, 2026, 13:14Eirini Kontou: Launch of the e-Optimism Research Study to Support Life After TIA and Minor Stroke
-
Feb 13, 2026, 13:11Omar Adwan: Understanding ITP, TTP, and DIC
-
Feb 13, 2026, 13:01Abhishek Kumar: The Future of Uncontrolled Bleeding Therapies and the Evolving Hemostasis Pipeline
-
Feb 13, 2026, 12:49Simon Senanu: ‘Within Range’ Is Not the Same as ‘Safe’ in Laboratory Medicine
-
Feb 13, 2026, 12:35Heghine Khachatryan: Advances in Targeted Therapy Transforming TTP Management at ASH Highlights 2026
-
Feb 13, 2026, 12:03Prabineshwor Prasad Lekhak: Saving a Girl with Hemophilia When Every Drop Counts
-
Feb 13, 2026, 11:37Finn Guo: Access and Affordability Challenges for Von Willebrand Disease in China
-
Feb 13, 2026, 11:31Sami Maja: I Presented My Master’s Thesis on Venous Occlusion Plethysmography at LFT Days 2026